SCHEMBL2554935

SCHEMBL2554935

CCCC(SC)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18786585 0.86 CA2 (0.50)
SCHEMBL874009 0.86 CA2 (0.50)
SCHEMBL873926 0.82 GPR84 (0.55)
SCHEMBL9567321 0.82 GPR84 (0.55)
SCHEMBL15751022 0.82 CHRM1 (0.52)
SCHEMBL19812464 0.82 CHRM1 (0.52)
SCHEMBL1751916 0.81 CHRM1 (0.46)
SCHEMBL11571764 0.81 GPR84 (0.53)
SCHEMBL14155865 0.80
Ammonia Solution, Strong SCHEMBL8650330 0.80 RNPEP (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220112451-A1 BOURBON REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS AVA FOOD LABS, INC. 2022-04-14 US disclosed
US-20220010248-A1 SCOTCH REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS AVA FOOD LABS, INC. 2022-01-13 US disclosed
US-20210289794-A1 COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE FLAGSHIP PIONEERING INNOVATIONS V, INC. 2021-09-23 US disclosed
US-20210198603-A1 ALCOHOLIC BEVERAGES PRODUCED FROM INDIVIDUAL COMPONENTS AVA FOOD LABS, INC. 2021-07-01 US disclosed
US-20200406187-A1 Method for Purifying a Gaseous, Liquid or Aerosol Composition Containing at Least One Polluant DAVID PHILIPPE (FR) 2020-12-31 US disclosed
EP-3624926-A1 METHOD FOR PURIFYING A GASEOUS, LIQUID OR AEROSOL COMPOSITION CONTAINING AT LEAST ONE POLLUANT David, Philippe (FR) 2020-03-25 EP disclosed
CN-106478453-A Oxime derivatives and its application as FXR antagonist 上海医药工业研究院 2017-03-08 CN disclosed
EP-2556051-A1 PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACIDS Sumitomo Chemical Company, Limited (JP) 2013-02-13 EP disclosed
EP-2556052-A1 PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACIDS Sumitomo Chemical Company, Limited (JP) 2013-02-13 EP disclosed
WO-2011126130-A1 PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACIDS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-10-13 WO disclosed
WO-2011126129-A1 PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACIDS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-10-13 WO disclosed
EP-2257630-A2 BIOSYNTHETIC ENGINEERING OF GLUCOSINOLATES University of Copenhagen (DK) 2010-12-08 EP disclosed
WO-2009106985-A2 BIOSYNTHETIC ENGINEERING OF GLUCOSINOLATES UNIVERSITY OF COPENHAGEN (DK) 2009-09-03 WO disclosed
US-7524659-B2 Isogenic strain line of bacterium for producing polyhydroxyalkanoate in which polyhydroxyalkanoate synthase gene is disrupted and method for producing polyhydroxyalkanoate using the same CANON KABUSHIKI KAISHA (JP) 2009-04-28 US disclosed
US-7235396-B2 Bacterium for producing polyhydroxyalkanoate having polyhydroxyalkanoate depolymerase gene disrupted and method for producing polyhydroxyalkanoate using the same CANON KABUSHIKI KAISHA (JP) 2007-06-26 US disclosed
US-20060172400-A1 Bacterium for producing polyhydroxyalkanoate having polyhydroxyalkanoate depolymerase gene disrupted and method for producing polyhydroxyalkanoate using the same CANON KABUSHIKI KAISHA (JP) 2006-08-03 US disclosed
US-20060172398-A1 Isogenic strain line of bacterium for producing polyhydroxyalkanoate in which polyhydroxyalkanoate synthase gene is disrupted and method for producing polyhydroxyalkanoate using the same CANON KABUSHIKI KAISHA (JP) 2006-08-03 US disclosed
EP-1196436-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE Bristol-Myers Squibb Pharma Company (US) 2002-04-17 EP disclosed
WO-2001002424-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE DU PONT PHARMACEUTICALS COMPANY (US) 2001-01-11 WO disclosed